THURSDAY, May 11, 2023 (HealthDay News) — A medication to treat agitation in Alzheimer’s patients now has approval from the U.S. Food and Drug Administration. The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti is the first FDA-approvedContinue Reading

THURSDAY, May 11, 2023 (HealthDay News) — Poor sleep brought on by sleep apnea may ultimately undermine the brain health of older men and women, new research suggests. The concern stems from a new brain scan investigation that involved 140 sleep apnea patients. “Sleep apnea is a medical condition inContinue Reading

WEDNESDAY, May 10, 2023 (HealthDay News) — Researchers have isolated for the first time a free-floating form of amyloid beta that appears to be a key driver of Alzheimer’s disease. Further, they argue that a newly approved Alzheimer’s drug — lecanemab (Leqembi) — directly targets these small, complex chains ofContinue Reading

WEDNESDAY, May 10, 2023 (HealthDay News) — Marijuana appears to significantly increase young men’s risk of developing schizophrenia, a new study suggests. Up to 30% of schizophrenia cases among men aged 21 to 30 are related to heavy and problematic use of marijuana, according to the findings. The researchers alsoContinue Reading

WEDNESDAY, May 10, 2023 (HealthDay News) — Toxic chemicals that develop from car exhaust, smoking and backyard grilling might increase your risk of developing the autoimmune disease rheumatoid arthritis, a new study suggests. These chemicals are called polycyclic aromatic hydrocarbons (PAHs). They form as coal, oil, gas, wood or tobaccoContinue Reading